The cyclotron/radiochemistry core can help in developing new radiopharmaceuticals using conventional PET (11C & 18F), or non-conventional PET (64Cu, 89Zr, 124I), SPECT (99mTc, 111In, 123I) and therapeutic (90Y, 131I, 177Lu) isotopes.
The core director has successfully developed a number of imaging and therapeutic agents as well as translating them into the clinic.
cGMP and GLP compliant synthesis facilities
Licensed for radioactive laboratory work
Cell harvester – receptor binding studies
Radio HPLC – metabolite analysis